We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
All people are not the same. While glaringly obvious, that truth is often ignored in clinical trials. And fixing that problem requires companies to understand and overcome a myriad of barriers, according to a panel discussion held at the annual meeting of the Regulatory Affairs Professionals Society (RAPS) in Phoenix this week. Read More
South Korea’s Lunit INSIGHT CXR artificial intelligence (AI) system improved radiologists’ findings in chest X-rays in four abnormalities, according to study findings published in JAMA Network Open on Aug. 31. Read More
Three-year results continue to show that Abbott’s Amplatzer Piccolo Occluder, which was approved by the FDA in 2019, is safe and effective in nonsurgically closing a hole in the heart of premature infants. Read More
AposHealth’s Apos biomechanical knee treatment helped most patients suffering from disabling osteoarthritis (OA) to be able to delay knee replacement surgery for 24 months, according to data from an observational study published in the journal Population Health Management. Read More
A group of researchers representing devicemakers, academic institutions and the FDA has published a list of factors device developers should consider when collecting patient preference information (PPI) to help design trials. Read More
Medcura’s injectable biopolymer LifeFoam significantly extended survival time in an animal study, researchers reported in the journal Surgery. Read More
Patients with type 1 diabetes using Medtronic’s MiniMed 780G insulin pump system had reduced blood glucose levels and increased time spent in the target blood sugar range compared to patients given insulin injections, researchers reported in the journal The Lancet Diabetes & Endocrinology. Read More
Nearly 60 percent of patients using Abbott’s Heartmate 3 heart pump are reaching the five-year survival mark, according to results of a postmarket study reported at the 2022 European Society of Cardiology Congress in Barcelona, Spain, Aug. 26-29. Read More
MIT researchers have developed a device that uses artificial intelligence (AI) to detect Parkinson’s disease by monitoring a person’s breathing patterns while they sleep. Read More
Penumbra’s RED reperfusion catheter was effective in removing blood clots in acute eschemic stroke (AIS) patients, according to study data reported at the 2022 World Federation of Interventional and Therapeutic Neuroradiology (WFITN) in Kyoto, Japan, last week. Read More
Bioretec’s ActivaPin bioresorable implant has proven to be an acceptable alternative treatment for pediatric elbow fractures, researchers reported in the journal Medicine.